DR. DAVID G BJORAKER, MD
Anesthesiologist Assistant at Archer Rd, Gainesville, FL
License number
Florida ME42083
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
2
1600 SW Archer Rd, Gainesville, FL 32610
PO Box 918025, Orlando, FL 32891
PO Box 918025, Orlando, FL 32891
Phone
(352) 265-0077
(352) 265-0443 (Fax)
(352) 265-0443 (Fax)
Personal information
See more information about DAVID G BJORAKER at radaris.comName
Address
Phone
10606 SW 41St Pl, Gainesville, FL 32608
Ruskin, FL
Gainesville, FL
6307 Cocoa Ln, Apollo Beach, FL 33572
10606 41St St, Gainesville, FL 32608
Organization information
See more information about DAVID G BJORAKER at bizstanding.comUniversity Of Florida - David G Bjoraker MD
1600 SW Archer Rd #D6-33, Gainesville, FL 32610
Categories:
Anesthesiology Physicians
Site:
Phone:
(352) 265-0077 (Phone)
Professional information
David Gary Bjoraker, Gainesville FL
Specialties:
Anesthesiologist
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
University of Minnesota, Medical School - Doctor of Medicine
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Anesthesiology
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Anesthesiology
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology
David Gary Bjoraker, Gainesville FL
Specialties:
Anesthesiology
Work:
University of Florida
1600 Sw Archer Rd, Gainesville, FL 32610
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
University of Minnesota, Twin Cities (1972) Anesthesiology
Dr. David G Bjoraker, Gainesville FL - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
Gainesville
1600 SW Archer Rd SUITE 100254, Gainesville 32610
(352) 265-0111 (Phone)
1600 SW Archer Rd SUITE 100254, Gainesville 32610
(352) 265-0077 (Phone), (352) 265-0443 (Fax)
1600 SW Archer Rd SUITE 100254, Gainesville 32610
(352) 265-0111 (Phone)
1600 SW Archer Rd SUITE 100254, Gainesville 32610
(352) 265-0077 (Phone), (352) 265-0443 (Fax)
Certifications:
Anesthesiology, 1976
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Mn Med Sch
Graduated: 1972
U Colo Med Ctr
University of Mn Med Sch
Graduated: 1972
U Colo Med Ctr
Method And Apparatus For Monitoring Intravenous (Iv) Drug Concentration Using Exhaled Breath
US Patent:
2003013, Jul 24, 2003
Filed:
Jan 22, 2002
Appl. No.:
10/054619
Inventors:
Richard Melker - Gainesville FL, US
David Bjoraker - Gainesville FL, US
David Bjoraker - Gainesville FL, US
International Classification:
A61B005/08
US Classification:
600/532000
Abstract:
A method and system is provided for detecting the depth of anesthesia wherein at least one anesthetic agent is absorbed in a patient's bloodstream during the administration of anesthesia, which includes sampling a patient's expired breath; analyzing the breath for concentration of at least one substance indicative of the anesthetic agent using sensor technology such as free (unmetabolized) anesthetic agent or its metabolites; determining the effect of the agent based on that concentration; and determining depth of anesthesia based thereon. The method also detects endogenous compounds such as ketones and ammonia in exhaled breath as well as other pathologic organisms.
Detection And Measurement Of Hematological Parameters Characterizing Cellular Blood Components
US Patent:
2006025, Nov 16, 2006
Filed:
May 10, 2005
Appl. No.:
11/125937
Inventors:
David Bjoraker - Gainesville FL, US
Richard Melker - Gainesville FL, US
Donn Dennis - Gainesville FL, US
Richard Melker - Gainesville FL, US
Donn Dennis - Gainesville FL, US
International Classification:
C12Q 1/68, G01N 33/92, G01N 33/00
US Classification:
435006000, 436071000, 436086000
Abstract:
Systems and methods for the diagnostic analysis of blood samples. The present invention uses sensor technology useful in the analysis of headspace sample from blood to provide an efficient and accurate means for identifying the presence of a volatile marker associated with hematological diseases or conditions. In a preferred embodiment, the sensor technology of the present invention includes detecting means such as RNA oligonucleotide chains or aptamers.
System And Method For Monitoring Health Using Exhaled Breath
US Patent:
8211035, Jul 3, 2012
Filed:
Aug 29, 2006
Appl. No.:
11/512856
Inventors:
Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Samsun Lampotang - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Samsun Lampotang - Gainesville FL, US
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
A61B 5/08, A61M 31/00
US Classification:
600532, 604512
Abstract:
The present invention includes systems and methods for monitoring endogenous compound concentration in blood by detecting markers, such as odors, upon exhalation by a patient, wherein such markers are the endogenous compound itself or result from the endogenous compound. In the case of olfactory markers, the invention preferably utilizes electronic sensor technology, such as the commercial devices referred to as “artificial” or “electronic” noses or tongues, to non-invasively monitor endogenous compound levels in blood. The invention further includes a reporting system capable of tracking endogenous compound concentrations in blood (remote or proximate locations) and providing the necessary alerts with regard to emergent or harmful conditions in a patient.
System And Method For Monitoring Health Using Exhaled Breath
US Patent:
2012001, Jan 19, 2012
Filed:
Sep 27, 2011
Appl. No.:
13/246436
Inventors:
Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
International Classification:
A61B 5/08
US Classification:
600532
Abstract:
The present invention includes systems and methods for monitoring endogenous compound concentration in blood by detecting markers, such as odors, upon exhalation by a patient, wherein such markers are the endogenous compound itself or result from the endogenous compound. In the case of olfactory markers, the invention preferably utilizes electronic sensor technology, such as the commercial devices referred to as “artificial” or “electronic” noses or tongues, to non-invasively monitor endogenous compound levels in blood. The invention further includes a reporting system capable of tracking endogenous compound concentrations in blood (remote or proximate locations) and providing the necessary alerts with regard to emergent or harmful conditions in a patient.
Condensate Glucose Analyzer
US Patent:
2010021, Aug 26, 2010
Filed:
Aug 15, 2007
Appl. No.:
12/374564
Inventors:
Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Donn Michael Dennis - Gainesville FL, US
Jon Dale Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
John Frederick Horn - Orange Park FL, US
Ronald Youngblood - Williston FL, US
Timothy E. Morey - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Donn Michael Dennis - Gainesville FL, US
Jon Dale Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
John Frederick Horn - Orange Park FL, US
Ronald Youngblood - Williston FL, US
Timothy E. Morey - Gainesville FL, US
International Classification:
C12Q 1/54, C12M 1/34, G01N 33/497, G01N 27/26
US Classification:
435 14, 422 84, 4352879, 436 95, 20440301, 20440314
Abstract:
Systems and methods for analyzing glucose present in exhaled breath condensate (EBC). In certain embodiments, electrochemical- or coulometnc-based sensing technologies are used to analyze EBC for the presence and/or concentration of glucose. Based on the detected glucose m EBC, the subject invention provides systems and methods for non-invasive, accurate assessment of blood glucose levels.
System And Method For Monitoring Health Using Exhaled Breath
US Patent:
2007016, Jul 19, 2007
Filed:
Dec 13, 2005
Appl. No.:
11/301911
Inventors:
Richard Melker - Gainesville FL, US
Donn Dennis - Gainesville FL, US
David Bjoraker - Gainesville FL, US
Mark Gold - Gainesville FL, US
Donn Dennis - Gainesville FL, US
David Bjoraker - Gainesville FL, US
Mark Gold - Gainesville FL, US
International Classification:
A61B 5/08
US Classification:
600532000, 600529000
Abstract:
The present invention includes systems and methods for monitoring endogenous compound concentration in blood by detecting markers, such as odors, upon exhalation by a patient, wherein such markers are the endogenous compound itself or result from the endogenous compound. In the case of olfactory markers, the invention preferably utilizes electronic sensor technology, such as the commercial devices referred to as “artificial” or “electronic” noses or tongues, to non-invasively monitor endogenous compound levels in blood. The invention further includes a reporting system capable of tracking endogenous compound concentrations in blood (remote or proximate locations) and providing the necessary alerts with regard to emergent or harmful conditions in a patient.
Condensate Glucose Analyzer
US Patent:
7914460, Mar 29, 2011
Filed:
Aug 15, 2006
Appl. No.:
11/504335
Inventors:
Richard J. Melker - Gainesville FL, US
David G. Bjoraker - Gainesville FL, US
Donn M. Dennis - Gainesville FL, US
Jon D. Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
Ronald E. Youngblood - Williston FL, US
David G. Bjoraker - Gainesville FL, US
Donn M. Dennis - Gainesville FL, US
Jon D. Stewart - Gainesville FL, US
Christopher D. Batich - Gainesville FL, US
Matthew M. Booth - Gainesville FL, US
Ronald E. Youngblood - Williston FL, US
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
Xhale, Inc. - Gainesville FL
Xhale, Inc. - Gainesville FL
International Classification:
A61B 5/08, A61B 5/00
US Classification:
600532, 600365, 600529, 600543
Abstract:
The present invention provides systems and methods for analyzing glucose present in exhaled breath condensate (EBC). In certain embodiments of the invention, electrochemical- or coulometric-based sensing technologies are used to analyze EBC for the presence and/or concentration of glucose.